New Delhi, Jan. 29 -- The conclusion of the India-EU Free Trade Agreement (India-EU FTA) has opened major opportunities for the two regions to emerge as a global supplier of affordable and quality medicines, according to the Indian Pharmaceutical Alliance (IPA).

Speaking on the significance of the agreement, Sudarshan Jain, General Secretary, Indian Pharmaceutical Alliance, said that the India-EU FTA is a landmark development, particularly for the pharmaceutical sector.

"The conclusion of India-EU FTA is a landmark moment as it covers 25 per cent of the global GDP and 23 per cent of the world population. This FTA is very important in the context of pharmaceuticals. It will further strengthen the relationship between India and the EU," h...